UNVERIFIEDSingle SourceSTAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loomStat News|4/21/2026
UNVERIFIEDSingle SourceRoche's multiple sclerosis drug fenebrutinib meets goal in late-stage trialReuters|2/7/2026
UNVERIFIEDSingle SourceNext-generation obesity drug from Chugai and Roche aims to stop reboundsNikkei Asia|1/25/2026